End results in central precocious puberty with GnRH analog treatment: The data of the Italian Study Group for Physiopathology of Puberty

Journal of Pediatric Endocrinology and Metabolism

Volumn 13, Issue SUPPL. 1, 2000, Pages 773-780

  Antoniazzi, F ^a   Arrigo, T ^a   Cisternino, M ^a   Galluzzi, F ^a   Bertelloni, S ^a   Pasquino, A M ^a   Borrelli, P ^a   Osio, D ^a   Mengarda, F ^a   De Luca, F ^a   Tato, L ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Bone mineral density; Central precocious puberty; Final height; GnRH agonists

Indexed keywords

BUSERELIN; GONADORELIN DERIVATIVE; TRIPTORELIN;

BODY COMPOSITION; BODY HEIGHT; BONE DENSITY; BONE MINERAL; CHILD; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRECOCIOUS PUBERTY; PUBERTY; REPRODUCTION; RETROSPECTIVE STUDY;

EID: 0033858107     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/jpem.2000.13.s1.773     Document Type: Conference Paper

References (35)

1. Precocious puberty. A report of 96 cases
2. Clinical review: Pathophysiology and treatment of sexual precocity
3. Long term treatment of male and female precocious puberty by periodic administration of a long acting preparation of D-Trp6-luteinizing hormone-releasing hormone microcapsules
4. Treatment of idiopathic precocious puberty by a long-acting LH-RH analogue (D-Trp6-LHRH)
5. Pubertal development, growth and final height in girls with sexual precocity after therapy with the GnRH analogue D-Trp-6-LH-RH. A report on 15 girls, followed after cessation of gonadotrophin suppressive therapy
6. Final heights in girls with central precocious puberty following GnRH agonist induced pituitary-gonadal suppression
7. Adult height in precocious puberty after long-term treatment with deslorelin
8. Long-term results with a slow-release gonadotrophin-releasing hormone agonist in central precocious puberty. Dutch-German Precocious Puberty Study Group
9. Taille definitive des pubertes precoces
10. Preserving adult height potential in girls with idiopathic true precocious puberty
11. Gonadotropin secretory dynamics during puberty in normal girls and boys
12. Standards for children's height at ages 2-9 years allowing for height of parents
13. Bayley-Pinneau, Roche-Wainer-Thissen, and Tanner height predictions in normal children and in patients with various pathologic conditions
14. Ovulation and menstrual function of adolescent girls with central precocious puberty after therapy with gonadotropin-releasing hormone agonists
15. Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: Long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty
16. Effects of luteinizing hormone-releasing hormone agonists on final height in luteinizing hormone-releasing hormone-dependent precocious puberty
17. Final height in girls with central precocious puberty. Comparison of two different luteinizing hormone-releasing hormone agonist treatments
18. Analysis of the factors affecting auxological response to GnRH agonist treatment and final height outcome in girls with idiopathic central precocious puberty
19. Final height in central precocious puberty after long term treatment with a slow release GnRH agonist
20. Final height after long-term treatment with triptorelin slow release for central precocious puberty: Importance of statural growth after interruption of treatment. French Study Group of Decapeptyl in Precocious Puberty
21. Long-term effect of gonadotropin-releasing hormone agonist therapy on final and near-final height in 26 children with tree precocious puberty treated at a median age of less than 5 years
22. Randomised trial of LHRH analogue treatment on final height in girls with onset of puberty aged 7.5-8.5 years
23. Lack of effect of GnRH agonists on final height in girls with advanced puberty: A randomized long-term pilot study
24. Use of combined Gn-RH agonist and hGH therapy for better attaining the goals in precocious puberty treatment
25. Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone analogues and growth hormone
26. Reduction of bone density: An effect of gonadotropin releasing hormone analogue treatment in central precocious puberty
27. Bone mineral metabolism in girls with precocious puberty during gonadotropin releasing hormone agonist treatment
28. Bone mineral content in girls with precocious puberty treated with gonadotropin-releasing hormone analog
29. Bone mineral density during treatment of central precocious puberty
30. Prevention of bone demineralization by calcium supplementation in precocious puberty during gonadotropin-releasing hormone agonist treatment
31. Effect of central precocious puberty and gonadotropin-releasing hormone analogue treatment on peak bone mass and final height in females
32. Long-term outcome aider depot gonadotropin-releasing hormone agonist treatment of central precocious puberty: Final height, body proportions, body composition, bone mineral density, and reproductive function